Peter Salzmann
Chief Executive Officer at Immunovant Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Immunovant Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Immunovant Inc. August 12, 202475.8%
-
Corbus Pharmaceuticals Holdings Inc. May 16, 202499.7%
-
Immunovant Inc. August 21, 202384.8%
-
Corbus Pharmaceuticals Holdings Inc. May 18, 202388.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 16, 2025 | Immunovant Inc. | Open-market sale | −8,321 | $14.89 | $123,900 |
| Apr 9, 2025 | Immunovant Inc. | Open-market sale | −28,094 | $12.99 | $364,941 |
| Apr 1, 2025 | Immunovant Inc. | Grant or award | +265,820 | — | — |
| Feb 19, 2025 | Immunovant Inc. | Open-market sale | −15,439 | $20.86 | $322,058 |
| Jan 15, 2025 | Immunovant Inc. | Open-market sale | −8,352 | $23.81 | $198,861 |
| Jan 15, 2025 | Immunovant Inc. | Open-market sale | −415 | $24.19 | $10,039 |
| Jan 8, 2025 | Immunovant Inc. | Open-market sale | −5,105 | $24.10 | $123,031 |
| Nov 20, 2024 | Immunovant Inc. | Open-market sale | −16,692 | $25.45 | $424,811 |
| Oct 16, 2024 | Immunovant Inc. | Open-market sale | −9,095 | $28.79 | $261,845 |
| Oct 9, 2024 | Immunovant Inc. | Open-market sale | −4,460 | $29.56 | $131,838 |
| Aug 21, 2024 | Immunovant Inc. | Open-market sale | −14,470 | $31.84 | $460,725 |
| Aug 21, 2024 | Immunovant Inc. | Open-market sale | −598 | $32.32 | $19,327 |
| Jul 17, 2024 | Immunovant Inc. | Open-market sale | −8,175 | $29.64 | $242,307 |
| Jul 17, 2024 | Immunovant Inc. | Open-market sale | −510 | $30.55 | $15,581 |
| Jul 9, 2024 | Immunovant Inc. | Open-market sale | −4,619 | $28.06 | $129,609 |
Questions about Peter Salzmann
What boards is Peter Salzmann on?
Peter Salzmann sits on the boards of Corbus Pharmaceuticals Holdings Inc. and Immunovant Inc.
What company is Peter Salzmann the CEO of?
Peter Salzmann is Chief Executive Officer of Immunovant Inc.
How long has Peter Salzmann served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.